🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of the drug olaparib at dif...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Start Date
2014-04-21
Trial ID
NCT02121990
Treatments Being Tested
RATIONAL FOR STUDYING IV NAC AS POTENTIAL CHEMOPROTECTANT: Cisplatin has s...
Status
Withdrawn
Location
Oregon Health & Science University
Start Date
2010-06
Trial ID
NCT01138137
Treatments Being Tested
This is an open-label, single-group, multi-centre trial to confirm the safe...
Status
Completed
Location
Fukuwa Clinic
Start Date
2016-07-27
Trial ID
NCT02831569
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-02
Trial ID
NCT00006038
Treatments Being Tested
This is a multicenter, randomized, double-blind, active-controlled, paralle...
Status
Completed
Location
Korea University Anam Hospital
Start Date
2025-04-21
Trial ID
NCT07444762
Treatments Being Tested
Bile duct tumours are rare. They are the 6th most common type of digestive ...
Status
Completed
Location
Chu Picardie
Start Date
2015-12-15
Trial ID
NCT02591030
Treatments Being Tested
This clinical trial tests different programs to help patients with acute ly...
Status
Suspended
Location
Children's Hospital of Alabama
Start Date
2024-12-04
Trial ID
NCT06639958
Treatments Being Tested
RATIONALE: Pemetrexed may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
Arizona Oncology - Scottsdale
Start Date
2007-09
Trial ID
NCT00702299
Treatments Being Tested
The purpose of this phase I study is to test the safety of different dose l...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2015-08
Trial ID
NCT02498912
This phase I trial studies the side effects and best dose of intraperitonea...
Status
Completed
Location
Hartford Hospital
Start Date
2008-01-17
Trial ID
NCT00575952
Treatments Being Tested